Pentafarma


Pentafarma started its activity in 1992, being its creation a natural response to the development of the Tecnimede Group in Portugal.

Currently, Pentafarma focuses its activity on the following therapeutic areas: Anti-Infectious, Urology, Central Nervous System, Cardiology and Gastroenterology.